News
Oxgene introduces TESSA technology for plasmid-free manufacturing system for...
Oxgene, a biotechnology company designing and developing scalable gene therapy technologies, has announced the launch of its scalable, plasmid-free manufacturing system for Adeno-associated virus (AAV)....
Clinical Trials
Bharat Biotech to collaborate with Washington University School of...
Vaccine maker Bharat Biotech has entered into an agreement with Washington University School of Medicine in St. Louis as part of which it will conduct...
Clinical Trials
I-Mab receives China NMPA clearance to begin phase 1...
I-Mab, a clinical stage biopharmaceutical company, announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has cleared the...
News
US FDA grants fast track status to Gyroscope’s GT005...
Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, announced that the US FDA has granted Fast Track designation to GT005 for the treatment of...
News
AstraZeneca’s Lynparza recommended by the EMA for HRD-positive advanced...
AstraZeneca and MSD’s Lynparza (olaparib) has been recommended for marketing authorisation across the European Union for the first-line maintenance treatment with bevacizumab for patients with...
News
Bristol Myers Squibb Completes Acquisition of Forbius
Bristol Myers Squibb announced that it has successfully completed its transaction to acquire Forbius for their TGF-beta program, including its lead investigational asset AVID200, currently...
News
Russia Expects To Register Second COVID-19 Vaccine EpiVacCorona By...
Russia expects to register another COVID-19 vaccine candidate by mid-October, according to Russian consumer safety watchdog Rospotrebnadzor.
Russia expects to register another COVID-19 vaccine candidate by...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.